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A B S T R A C T
R ecen tly , the q uestions o f  the lim ited  op portu n ities for m easu rem ent o f  the subjective and often  su bclin ica l v i­
sual d ysfunction  are very  topical. N E I-V F Q , the questionn aire o f  the N ational E ye In stitu te in the U SA  and  
V F Q -25, its sh ort version  (25-item  V ision  Function  Q u estion naire) are va lid ated  for v isu a l-sp ecific  assess­
m ent o f  the quality  o f  life o f  m ultip le sclerosis (M S) patients. M S V Q -7, a specific 7-item  M S V ision  Q u estion ­
n aire is p rop osed , too. T he au thors used the V F Q -25 translated  into B ulgarian , the M S V Q -7 and their  
correlation  w ith  the b inocular v isual acuity. T h ese questionn aires w ere ad m in istered  to 108 M S p atients w ith ­
out h istory o f  optic n euritis and  after optic neuritis as w ell registered  in the M S C entre in V arna and to 30  
h ealthy  subjects. T h ere w as a statistica lly  sign ifican t d ifferen ce (p< 0,0001) betw een M S p atients and controls  
in all sub-sca les and in the overall resu lts from  V F Q -25. T h e an alysis o f  M S V Q -7 show ed  a sta tistica lly  sign ifi­
cant d ifferen ce betw een  the answ ers o f  question  Nos 1 , 2 , 3  and 5 (p<0,001 to p=0,015). T he correlation  o f  the 
resu lts from  V F Q -25 and the b inocu lar v isu a l acu ity  w as m oderate (Sp earm an 's r=0,6; p <0,01).T h e ap p lica­
tion o f  q uestionn aires for assessm ent o f  v isu al function  m ay con trib ute to the identification  o f  less know n and  
sou ght su bclin ica l v isu al dysfu nctions that ap pear in norm al v isu al acu ity . O ur data confirm  the p ossib le us­
age o f  V F Q -25 and M S V Q -7 for effective m easu rem ent o f  the su bjective v isu al d eficit in M S diagnosis.
K ey  w ord s: m u ltip le  sc le ro sis , v isu a l q u es tio n n a ire s , v isua l d y sfu n c tio n , v isu a l acu ity , ea rly  d ia g n o sis
IN T R O D U C T IO N
Multiple sclerosis (MS) may have a  considerable and ex­
tended negative effect on the patient's quality o f  life. This 
inflammatory demyelinating disease o f  the central nervous 
system arising in relatively young people aged between 20 
and 40 years sometimes provokes chronic and heavy dis­
ability. The motion deficit is usually cited as the most fre­
quent cause for deterioration o f  quality o f  life. Its impact in 
this case may not be entirely proved by the com mon assess­
ment o f  the neurological disturbances. Less attention is paid 
to the visual dysfunction, especially the subjective, usually 
subclinical visual dysfunction in MS patients leading to dif­
ficulties in daily activity (1,7,14). In some cases patients do 
not manage to characterize it, especially when visual dis­
comfort is present with normal visual acuity (£1,0). In the 
so-called subclinical visual dysfunction the patients' expla­
nations are usually limited to: 'There is something with my 
eyes', 'washed-out', or 'blurred vision' (3,6,8). During the 
last few years, the question for the limited possibilities for
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assessment and measurement o f  this subjective complaint 
has become topical in the literature. In addition to the scales 
for evaluation o f  the neurological deficit o f  M S patients 
(among which the most commonly used is the exDanded 
disability status scale, EDSS) and o f  quality o f  life, 
HRQOL (Health Related Quality o f  Life), a  M S specific 
appendix, M SQLI (MS Quality o f  Life Inventory) was de­
veloped. Only through HRQOL and MSQLI scales it is 
possible to establish how health problems reflect on pa­
tient's abilities and activities and to objectify patient's views 
on the impact o f  the disease or the treatment. M SQLI con­
tains a part o f  the basic questions o f  HRQOL and nine other 
scales related to different symptoms and aspects o f  the 
quality o f  life, including a scale for the visual dysfunction 
essential for MS patients. Notwithstanding with MSQLI 
development, the US NEI questionnaire for the visual func­
tion (NEI-VFQ) and its short variation VFQ-25 (25-item 
Visual Function Questionnaire) are an important contribu­
tion in the information for the visual function measurement 
with relation to the quality o f  life o f  MS patients. Though 
these tests are not MS-specific, studies show a  certain cor­
relation with other visual dysfunction investigation meth­
ods such as visual acuity, visual fields, contrast sensitivity, 
and colour vision, especially when the dignosis o f  MS is 
definite and the visual acuity is damaged. As a  MSQLI 
subscale, VFQ-25 and MS-specific question for visual
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function which is attached to it are sufficiently effective in 
measuring the existing subjective visual dysfunction in MS. 
According to some authors, the so-modified VFQ-25 
would increase the possibility to document and objectify 
the subclinical visual dysfunction in MS. The possibility 
VFQ-25 and other more MS-specific questionnaires to be 
included in the commonly accepted clinical scales for eval­
uation o f  disability in MS is widely discussed in the litera­
ture (2,4,5,9-13,15).
The present study aims at revealing the subjective visual 
dysfunction o f  MS patients using the 25-item National Eye 
Institute Visual Function Questionnaire (NEI VFQ-25) 
translated into Bulgarian and the short MS-specific ques­
tionnaire, M SVQ-7 and at assessing the questionnaire cor­
relation with the binocular visual acuity.
M A T E R IA L  A N D  M E T H O D S
Subjects
VFQ-25 was administered to 108 subjects with clinically 
definite MS randomly selected am ong 150 patients initially 
hospitalized in the 1st Clinic o f  Neurology, S t  Marina Uni­
versity Hospital o f  Varna, and dynamically followed-up in 
MS-Centre o f  Varna, and to 30 healthy controls. There 
were 31 men and 87 women aged 39,34 ±11,59 years with 
average duration o f  MS o f  5,7 years and binocular visual 
acuity 0,5. This single crosscut study covered 63 patients 
with no history of optic neuritis (ON) and 45 ones after ON 
(9 in acute phase and 36 after ON). In all cases a  routine 
neuro-opthalmological examination was performed 
inlcuding visual acuity test. EDSS average score was 3,4. 
Sixty 60 MS patients (30 with no history o f  ON and 30 after 
ON) and 30 controls were interviewed with the short 
MS-specific questionaire. The controls were selected after a 
routine neuro-ophthalmological test am ong the staff o f  Is1 
and 2nd Clinic o f  Neurology and students from Prof. 
Paraskev Stoyanov Medical University o f  Varna.
Table I. VFQ-25 - Subscales
General health (1 question) 
General vision ( 1 Q.)
Ocular pain (2 Q.)
Near activities (3 Q.) 
Distance activities (3 Q.)
Vision specific:
- Social functioning (2 Q.)
- Mental health (4 Q.)
- Role difficulties (2 Q.)
- Dependency (2 Q.)
- Driving (2 Q.)
- Colour vision ( I Q.)
- Peripheral vision ( I Q.)
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Thirty subjects were examined, all aged 37,77± 12,35 (9 
men and 21 women) with no data for disease o f  eyes, visual 
pathways, or central nervous system. The present refraction 
anomalies were corrected to >1,0.
Methods
Ouestionaires. Each patient and disease-free subject was in­
terviewed using the VFQ-25. It represents a short version o f  
the 51-item Questionnaire for visual function examination 
and is standardized for visual-specific evaluation o f  quality 
o f  life am ong different groups o f  patients with neurological 
diseases including MS (4).VFQ-25 includes 25 questions 
divided in 12 subscales (Table 1) that reflect the level o f  vi­
sual difficilties and the related restrictions in everyday ac­
tivities evaluated by a scale from 1 to 5 or 6, where 5 or 6 is 
the lowest level o f  function. The answers o f  the questions 
are consistent with the correction needed for every subject 
with glasses or contact lenses. VFQ-25 was administered in 
accordance with standard instructions and the results were 
processed according to the algorithm: the 25 questions were 
scaled trom 0 to 100, where 100 were the highest function 
level. The composite result was calculated as an average 
value o f  all answers for eveiy patient excluding the subscale 
concerning the overall health status.
The short MS-specific questionnaire, MSVQ-7, is pre­
sented on Table 2. The answers were evaluated using a 
scale from 0 ('This aspect o f  vision is not applicable to me'), 
1 - N o  problem' to 4 - 'Severe problem' and the results were 
processed and scaled from 0 to 100, where 100 were the 
highest function level.
Table 2. M SVQ -7 visual symptoms or activity
1. Difficulty with vision when your eyes are tired
2. Difficulty with your vision in bright sunlight
3. Feeling that your two eyes see differently
4. Difficulty looking at or using a computer
5. Feeling that your vision is blurry, not clear, or "fuzzy"
6. Trouble focussing on or following moving objects
7. Double vision
Visual acuity. The binocolar visual acuity with high con­
trast was examined by a projected numerical table. The test 
was binocular, thus, after the required correction, in accor­
dance with the commonly accepted opinion that in this way 
except the minimization o f  the fatigue, the different aspects 
o f  vision loss related to the everyday activities are most ade­
quately SDecified. The numbers from the table were listed 
one by one (max 54 numbers), and the respective Snellen 
visual acuity was calculated (max 1,5).
Statistical analysis. The mean scores and standard devia­
tions were calculated for every VFQ-25 subscale and for 
one composite result. The values obtained from the group 
o f  MS patients were compared with those o f  the controls by
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using two-tailed /-test. The mean score and the standard de­
viations o f  the answers to each o f  the 7 questions from 
MSVQ-7 were calculated. Patients' and healthy subjects' 
answers were compared through two-sample non-paramet- 
rical analysis o f  Kolmogorov-Smimov's and M ann-W hit­
ney's (/-test. The correlation between the total result from 
VFQ-25 and the visual acuity calculated on the basis o f  the 
number o f  identified characters in the group o f  patients was 
established through Spearman's correlation analysis.
R E S U L T S  A N D  D IS C U S S IO N
There was a  statistically significant difference (p<0,0001) 
between MS patients and controls in all subscales and in the 
total result from VFQ-25. The level o f  significance 
(p=0,001 ) was highest in the subscale reporting the colour 
vision, but not enough for the hypothesis to be rejected. 
Mean scores and standard deviations o f  the total result and 
the results from the 12 subscales am ong the groups o f  MS 
patients and controls are shown on Table 3.
Table 3. M ean scores and  standard deviations fro m  the 
general results and  the results fro m  the 12 sub-scales o f  
the groups o f  patients with M S and  controls






General health 56,94± 18,98 86,67*16,75 0,0001
General vision 73,33±20,09 90,67*12,36 0,0001
Ocular pain 66,19± 14,91 92,3*9,25 0,0001
Near activities 81,83±11,85 96,13*6,74 0,0001
Distance activities 79,78±13,19 95,3*7,% 0,0001
Social functioning 84,46± 12,53 99,2*2,99 0,0001
Mental health 82,29±11,21 95,%7±4,31 0,0001
Role difficulties 80,46± 12,08 98*4,47 0,0001
Dependency 80,35± 11,67 98,67*2,98 0,0001
Driving 74± 19,04 91,73*8,01 0,0001
Colour vision 90,05± 14,48 97,5*7,50 0,001
Peripheral vision 78,24*21,64 9833*6,24 0,0001
The analysis o f  M SVQ-7 showed a statistically significant 
difference between the answers o f  question N os 1,2 ,3  and 
5 (p<0,001 to p=0,015). The results for question N o 4 about 
the difficulties when working with a  computer were not 
subject to analysis because o f  the significant number o f  an­
swers 'This aspect o f  vision is not applicable to me'. Corre­
lation analysis showed a statistically insignificant difference 
in the answers o f  question 6 and 7 between controls and MS 
patients. The statistically significant difference for these an­
swers obtained by the Mann-W hitney U-test which re­
quired identical statistic distribution o f  both samples was 
rejected when the Kolmogorov-Smimov's test was applied. 
In 76% o f  the patients a  visual acuity o f  1,0 or better was re­
ported. The correlation o f  the total result o f  VFQ-25 with 
the examined binocular visual acuity (based on the number 
o f  correctly identified digits) was moderate (Spearman's 
r=0,6; p<0,01).
Table 4. N  on-parametric analysis o f  the M SVQ -7  
answers with two samples (controls and  patients) 




difficulty with vision when your 
eyes are tired
472.50 .000
difficulty with your vision in bright 
sun-light 507.00 .000
feeling that your two eyes see 
differently
580.50 .000
difficulty looking at or using a 
computer
715.00 .234
feeling that your vision is blurry, not 
clear, or "fuzzy"
431.00 .000
trouble focusing on or following 
moving objects
699.00 .022
double vision 750.00 .019
Table 5. N  on-parametric analysis o f  the M SVQ-7  
answers with two sam ples (controls and  patients) 




difficulty with vision when your eyes 
are tired
1.938 .001
difficulty with your vision in bright 
sun-light
1.640 .009
feeling that your two eyes see 
differently
1.565 .015
difficulty looking at or using a 
computer .988
.283
feeling that your vision is blurry, not 
clear, or "fuzzy"
2.162 .000
trouble focusing on or following 
moving objects
,%9 .305
double vision .745 .635
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The average values o f  VFQ-25 subscales and the calculated 
total result in MS patients were considerably lower than 
these o f  the controls. The largest value o f  significance level 
(p=0,001 ) was obtained in the subscale for colour vision 
where there only one question was included: 'How much 
difficulty do you have picking out and matching your own 
clothes? W e join the commonly accepted opinion in the lit­
erature that the question formulated in this manner may not 
always capture the frequent, though fine, troubles o f  colour 
vision in MS (9).
19%
1 . Vis. Ac. 1.5 
Ж11 Vis. Ac. 1.25 
Er I Vis. Ac.1.0 
CD Vis. Ac. 0.8 
I FI Vis. Ac. 0,6 
F- 1 Vis. Ac. 0.5
43%
Fig. 1. Percentage distribution o f  the visual acuity 
among the patients exam ined
The statistically significant difference between the answers 
o f  question Nos 1, 2, 5 o f  MSVQ-7 (p<0,001 to p=0,009) 
confirms the possibility to objectify subclinical visual dis­
turbances in MS through this specific questionnaire. The 
lack o f  statistically significant difference in the answers to 
question No 7 between the group o f  patients with MS and 
the controls could be explained with the effectuated 
cross-sectional study, i.e. by the moment of study there was 
a  small number o f  patients with double vision. After pro­
cessing the VFQ-25 results, important differences were re­
ported, though in M S patients the mean score o f  the binocu­
lar visual acuity was 1,0 or better. This is why MS patients 
even with normal visual acuity when compared with the 
controls demonstrated a high level o f  subjective visual dys­
function evaluated using VFQ-25. A range o f  studies prove 
that in MS there is an important subjective dysfunction that 
may not be established only by tests o f  visual acuity with 
high contrast, a parameter that is traditionally present in the 
scales for disability evaluation in MS (2,3,8). The applica­
tion o f  questionnaires for assessment o f  the visual function 
may contribute to the identification o f  these less known and 
sought subclinical visual dysfunctions appearing with nor­
mal visual acuity. The inclusion o f  VFQ-25 in the clinical 
scales for disability evaluation in MS in order to objectify 
more precisely the slight visual dysfunction in this disease 
is widely discussed. The addition o f  several questions more 
specific to MS (M SVQ-7) is proposed in order to obtain 
useful information for future studies o f  the visual dysfunc­
tion in MS (2,3,9). Our study confirms that both VFQ-25 
and M SVQ-7 can be used for more effective measurement 
o f  the subjective visual deficit in the diagnosis o f  MS.
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